Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
D.R. Horton
DHI
US Stock MarketDetailed Quotes
IOBT IO Biotech
- 0.766
- +0.006+0.84%
Close Dec 18 16:00 ET
- 0.778
- +0.012+1.62%
Pre 07:02 ET
50.44MMarket Cap-0.59P/E (TTM)
0.780High0.728Low208.78KVolume0.759Open0.759Pre Close159.20KTurnover0.75%Turnover RatioLossP/E (Static)65.88MShares2.09852wk High0.70P/B21.32MFloat Cap0.66052wk Low--Dividend TTM27.84MShs Float17.880Historical High--Div YieldTTM6.90%Amplitude0.660Historical Low0.762Avg Price1Lot Size
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
IO Biotech Stock Forum
IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study
IO Biotech announced promising Phase 2 results for its cancer vaccine IO102-IO103 combined with KEYTRUDA® in first-line metastatic lung cancer treatment. The study showed a 55% unconfirmed/48% confirmed overall response rate and 8...
loading...
No comment yet